Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods
171
Zitationen
28
Autoren
2025
Jahr
Abstract
The Prediction model Risk Of Bias ASsessment Tool (PROBAST) is used to assess the quality, risk of bias, and applicability of prediction models or algorithms and of prediction model/algorithm studies. Since PROBAST’s introduction in 2019, much progress has been made in the methodology for prediction modelling and in the use of artificial intelligence, including machine learning, techniques. An update to PROBAST-2019 is thus needed. This article describes the development of PROBAST+AI. PROBAST+AI consists of two distinctive parts: model development and model evaluation. For model development, PROBAST+AI users assess quality and applicability using 16 targeted signalling questions. For model evaluation, PROBAST+AI users assess the risk of bias and applicability using 18 targeted signalling questions. Both parts contain four domains: participants and data sources, predictors, outcome, and analysis. Applicability of the prediction model is rated for the participants and data sources, predictors, and outcome domains. PROBAST+AI may replace the original PROBAST tool and allows all key stakeholders (eg, model developers, AI companies, researchers, editors, reviewers, healthcare professionals, guideline developers, and policy organisations) to examine the quality, risk of bias, and applicability of any type of prediction model in the healthcare sector, irrespective of whether regression modelling or AI techniques are used.
Ähnliche Arbeiten
"Why Should I Trust You?"
2016 · 14.150 Zit.
A Comprehensive Survey on Graph Neural Networks
2020 · 8.543 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.047 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.410 Zit.
Analysis of Survival Data.
1985 · 4.379 Zit.
Autoren
- Karel G.M. Moons
- Johanna AAG Damen
- T. K. Kaul
- Lotty Hooft
- Constanza L. Andaur Navarro
- Paula Dhiman
- Andrew L. Beam
- Ben Van Calster
- Leo Anthony Celi
- Spiros Denaxas
- Alastair K. Denniston
- Marzyeh Ghassemi
- Georg Heinze
- André Pascal Kengne
- Lena Maier‐Hein
- Xiaoxuan Liu
- Patrícia Logullo
- Melissa D. McCradden
- Nan Liu
- Lauren Oakden‐Rayner
- Karandeep Singh
- Daniel Shu Wei Ting
- Laure Wynants
- Bada Yang
- Johannes B. Reitsma
- Richard D Riley
- Gary S. Collins
- Maarten van Smeden
Institutionen
- Utrecht University(NL)
- University Medical Center Utrecht(NL)
- Nuffield Orthopaedic Centre(GB)
- University of Oxford(GB)
- Harvard University(US)
- KU Leuven(BE)
- Massachusetts Institute of Technology(US)
- British Heart Foundation(GB)
- University College London(GB)
- University of Birmingham(GB)
- University College Birmingham(GB)
- Medical University of Vienna(AT)
- University of Cape Town(ZA)
- National Center for Tumor Diseases(DE)
- German Cancer Research Center(DE)
- Heidelberg University(DE)
- University Hospitals Birmingham NHS Foundation Trust(GB)
- NIHR Birmingham Biomedical Research Centre(GB)
- Hospital for Sick Children(CA)
- Duke-NUS Medical School(SG)
- Australian Centre for Robotic Vision(AU)
- University of Adelaide(AU)
- University of Michigan–Ann Arbor(US)
- Maastricht University(NL)